SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about loss of share certificates

25 Feb 2022 Evaluate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder of the Company, received from its Registrar and Transfer Agent, Link Intime India on February 25, 2022.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

140.60 -2.40 (-1.68%)
24-Apr-2026 10:43 View Price Chart
Peers
Company Name CMP
Syngene Internation. 420.95
Indegene 487.05
CMS Info Systems 307.65
JITF Infralogistics 305.80
Sagility 41.94
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×